XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.77%5.28B | 1.08%1.31B | 0.84%1.32B | 4.40%1.35B | 0.78%1.29B | 6.14%5.18B | 4.91%1.3B | 5.68%1.31B | 4.79%1.29B | 9.36%1.28B |
Operating revenue | 1.77%5.28B | 1.08%1.31B | 0.84%1.32B | 4.40%1.35B | 0.78%1.29B | 6.14%5.18B | 4.91%1.3B | 5.68%1.31B | 4.79%1.29B | 9.36%1.28B |
Cost of revenue | -2.47%3.48B | -1.14%864M | -3.16%858M | -1.44%891M | -4.10%865M | 2.89%3.57B | 0.97%874M | 1.07%886M | 1.99%904M | 7.71%902M |
Gross profit | 11.12%1.8B | 5.67%447M | 9.22%462M | 17.95%460M | 12.30%429M | 14.10%1.62B | 14.11%423M | 16.82%423M | 11.91%390M | 13.45%382M |
Operating expense | 6.02%1.09B | -0.38%260M | 3.46%269M | 1.19%255M | 19.84%308M | 3.52%1.03B | -0.04%261M | 8.97%260M | 2.90%252M | 2.64%257M |
Selling and administrative expenses | 0.83%847M | 0.47%216M | 0.96%211M | 1.43%213M | 0.49%207M | 8.81%840M | 7.29%215M | 12.12%209M | 9.55%210M | 6.46%206M |
Research and development costs | 0.00%74M | 5.56%19M | 5.56%19M | -5.26%18M | -5.26%18M | 12.12%74M | 9.76%18M | 9.09%18M | 13.77%19M | 15.85%19M |
Depreciation amortization depletion | 4.55%92M | 9.09%24M | 20.00%24M | 4.76%22M | -12.00%22M | -29.60%88M | -26.91%22M | -34.21%20M | -33.75%21M | -23.78%25M |
-Depreciation and amortization | 4.55%92M | 9.09%24M | 20.00%24M | 4.76%22M | -12.00%22M | -29.60%88M | -26.91%22M | -34.21%20M | -33.75%21M | -23.78%25M |
Other operating expenses | 182.14%79M | -83.33%1M | 15.38%15M | 0.00%2M | 771.43%61M | -12.50%28M | -57.75%6M | 145.28%13M | -58.33%2M | -9.09%7M |
Operating profit | 20.07%706M | 15.43%187M | 18.40%193M | 48.55%205M | -3.20%121M | 39.01%588M | 47.81%162M | 31.98%163M | 33.20%138M | 44.84%125M |
Net non-operating interest income expense | 3.76%-205M | 14.55%-47M | 1.82%-54M | 9.09%-50M | -12.50%-54M | -52.14%-213M | -41.39%-55M | -57.14%-55M | -64.18%-55M | -47.24%-48M |
Non-operating interest expense | -3.76%205M | -14.55%47M | -1.82%54M | -9.09%50M | 12.50%54M | 52.14%213M | 41.39%55M | 57.14%55M | 64.18%55M | 47.24%48M |
Other net income (expense) | 75.00%-5M | 80.00%-1M | 160.00%3M | 111.11%1M | -700.00%-8M | 23.08%-20M | 63.24%-5M | -47.06%-5M | -25.00%-9M | 44.44%-1M |
Gain on sale of security | 52.17%-11M | 25.00%-3M | ---- | 70.00%-3M | -150.00%-5M | -53.33%-23M | -135.29%-4M | -20.69%-7M | -104.08%-10M | 23.08%-2M |
Special income (charges) | 50.00%-5M | 33.33%-2M | --0 | --0 | -50.00%-3M | 33.33%-10M | 80.77%-3M | -1,100.00%-4M | -600.00%-1M | ---2M |
-Less:Other special charges | -50.00%5M | -33.33%2M | ---- | ---- | 50.00%3M | -33.33%10M | -80.77%3M | 1,100.00%4M | 600.00%1M | --2M |
Other non- operating income (expenses) | -15.38%11M | 100.00%4M | -50.00%3M | 100.00%4M | ---- | 225.00%13M | -45.95%2M | 200.00%6M | 180.00%2M | 275.00%3M |
Income before tax | 39.72%496M | 36.27%139M | 37.86%142M | 110.81%156M | -22.37%59M | 38.13%355M | 78.63%102M | 21.03%103M | 17.65%74M | 46.44%76M |
Income tax | 22.09%105M | -92.86%2M | 33.33%40M | 230.77%43M | 33.33%20M | 32.31%86M | 108.96%28M | 37.61%30M | -30.85%13M | 36.36%15M |
Net income | 45.35%391M | 85.14%137M | 39.73%102M | 85.25%113M | -36.07%39M | 40.10%269M | 69.34%74M | 15.32%73M | 38.32%61M | 49.14%61M |
Net income continuous Operations | 45.35%391M | 85.14%137M | 39.73%102M | 85.25%113M | -36.07%39M | 40.10%269M | 69.34%74M | 15.32%73M | 38.32%61M | 49.14%61M |
Minority interest income | 0 | 0 | 0.00%1M | 1M | -2M | 2M | 433.33%1M | 11.11%1M | 0 | 0 |
Net income attributable to the parent company | 46.44%391M | 87.67%137M | 40.28%101M | 83.61%112M | -32.79%41M | 39.06%267M | 65.91%73M | 15.38%72M | 38.32%61M | 46.99%61M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 46.44%391M | 87.67%137M | 40.28%101M | 83.61%112M | -32.79%41M | 39.06%267M | 65.91%73M | 15.38%72M | 38.32%61M | 46.99%61M |
Basic earnings per share | 47.11%1.78 | 90.91%0.63 | 39.39%0.46 | 88.89%0.51 | -33.33%0.18 | 40.70%1.21 | 65.00%0.33 | 17.86%0.33 | 35.00%0.27 | 50.00%0.27 |
Diluted earnings per share | 47.11%1.78 | 90.91%0.63 | 39.39%0.46 | 88.89%0.51 | -33.33%0.18 | 40.70%1.21 | 65.00%0.33 | 17.86%0.33 | 35.00%0.27 | 50.00%0.27 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |